secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2026-06-29T21:15:16+00:00
Accession:  0001493152-26-031124
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic enters $178K convertible note financing with Pacific Pier Capital
---------------------------------------------------------------------------

- Issued $178,410 convertible promissory note with 12% OID and 12% interest, maturing in 1 year.
- Conversion price: $0.06/share or 85% of lowest VWAP in prior 10 trading days.
- Net proceeds to Oncotelic ~$150,000 after buyer's $7,000 legal fee withholding.
- Issued 500,000 commitment shares as additional consideration to Pacific Pier.
- Prepayment allowed after 6 months; default interest rate of 16% upon event of default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315226031124/0001493152-26-031124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315226031124/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-031124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer